Lucid Diagnostics Inc. - Common Stock (NQ:LUCD)

0.6273 -0.0075 (-1.18%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lucid Diagnostics Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021

November 03, 2021

From PAVmed Inc. and Lucid Diagnostics Inc.

Via Business Wire

Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award

October 28, 2021

From Lucid Diagnostics Inc.

Via Business Wire

ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer

October 21, 2021

From Lucid Diagnostics Inc.

Via Business Wire

Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer

October 21, 2021

From Lucid Diagnostics Inc.

Via Business Wire

3 Stocks Insiders Are Buying ↗

October 21, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering

October 18, 2021

From Lucid Diagnostics Inc.

Via Business Wire

LUCD Stock IPO: 7 Things to Know as Lucid Diagnostics Starts Trading Today ↗

October 14, 2021

Unfortunately, today is a very red day for investors who got in on the recent LUCD stock IPO, with shares of this stock down more than 17%.

Via InvestorPlace

Topics Initial Public Offering

The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts ↗

October 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Catalyst Biosciences Announces Resignation Of CFO Catalyst Biosciences, Inc...

Via Benzinga

51 Biggest Movers From Friday ↗

October 18, 2021

Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...

Via Benzinga

Lucid Diagnostics Announces Pricing of Initial Public Offering

October 13, 2021

From PAVmed Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.